A detailed history of Black Barn Capital Partners LP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Black Barn Capital Partners LP holds 2,070,900 shares of ABUS stock, worth $6.59 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
2,070,900
Previous 2,070,900 -0.0%
Holding current value
$6.59 Million
Previous $6.4 Billion 24.6%
% of portfolio
1.05%
Previous 0.57%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.26 - $2.92 $4.68 Million - $6.05 Million
2,070,900 New
2,070,900 $5.34 Billion

Others Institutions Holding ABUS

About Arbutus Biopharma Corp


  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $477M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Black Barn Capital Partners LP Portfolio

Follow Black Barn Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Barn Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Black Barn Capital Partners LP with notifications on news.